Can better Doctor-Patient talks improve breast cancer care?
NCT ID NCT07578415
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether training doctors in shared decision-making and giving patients educational materials improves treatment conversations for HER2-negative metastatic breast cancer. 120 patients starting first-line therapy will be randomly assigned to receive the program or usual care. The goal is to see if these tools make patients feel more involved and satisfied with their treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Shared Decision Making (SDM) Support Program
- What this could lead to
- If successful, this could provide tools to help patients and doctors make better treatment decisions together, potentially improving patient satisfaction and well-being.
- What could go wrong
- This is a small, early-stage study (120 participants) testing a behavioral intervention, not a drug. It may not show a clear benefit or be generalizable to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?